Skip to main content

Table 2 Characterization of different CLENs developed from breast cells

From: Nano-formulations composed of cell membrane-specific cellular lipid extracts derived from target cells: physicochemical characterization and in vitro evaluation using cellular models of breast carcinoma

# Nanoliposomal Preparations Particle Size (nm) Zeta potential (mV)
1 Doxil LP 150 ± 2.0 - 23 ± 0.9
2 4 T1 CLENs 158 ± 1.9 - 17 ± 2.5
3 BT-20 CLENs 263 ± 1.4 - 21 ± 3.5
4 SK-BR-3 CLENs 187 ± 2.1 − 13 ± 1.1
5 CRL-2089 CLENs 203 ± 1.9 − 15 ± 1.3
6 SK-OV-3 CLENs 200 ± 2.2 − 11 ± 2.3